| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Medicine, University of New South Wales, and Departments of Immunology, Allergy, and Infectious Disease, St. George Hospital, Kogarah, New South Wales, Australia;
Department of Medicine, Microbiology, and Immunology, University of New South Wales, Kogarah, New South Wales, Australia;
Center of Virus Research, Westmead Millennium Institute, and University of Sydney, Westmeade, New South Wales, Australia; and
Faculty of Pharmacy, University of Sydney, New South Wales, Australia; and
¶ Department of Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA 02115
AIDS patients often contain HIV-1-infected mast cells (MCs)/basophils in their peripheral blood, and in vivo-differentiated MCs/basophils have been isolated from the blood of asthma patients that are HIV-1 susceptible ex vivo due to their surface expression of CD4 and varied chemokine receptors. Because IL-16 is a ligand for CD4 and/or an undefined CD4-associated protein, the ability of this multifunctional cytokine to regulate the development of human MCs/basophils from nongranulated progenitors residing in cord or peripheral blood was evaluated. After 3 wk of culture in the presence of c-kit ligand, IL-16 induced the progenitors residing in the blood of normal individuals to increase their expression of chymase and tryptase about 20-fold. As assessed immunohistochemically, >80% of these tryptase+ and/or chymase+ cells expressed CD4. The resulting cells responded to IL-16 in an in vitro chemotaxis assay, and this biologic response could be blocked by anti-IL-16 and anti-CD4 Abs as well as by a competitive peptide inhibitor corresponding to a sequence in the C-terminal domain of IL-16. The additional finding that IL-16 induces calcium mobilization in the HMC-1 cell line indicates that IL-16 acts directly on MCs and their committed progenitors. IL-16-treated MCs/basophils also are less susceptible to infection by an M/R5-tropic strain of HIV-1. Thus, IL-16 regulates MCs/basophils at a number of levels, including their vulnerability to retroviral infection.
This article has been cited by other articles:
|
|
 |
|
  E J Soilleux, J Bowling, and K Hollowood CD4 expression by mast cells in mastocytosis: a case report J. Clin. Pathol., June 1, 2009; 62(6): 564 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nechushtan and E. Razin Mast cells: must they always be different? Blood, January 1, 2006; 107(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
|
|
J. C. Qi, J. Wang, S. Mandadi, K. Tanaka, B. D. Roufogalis, M. C. Madigan, K. Lai, F. Yan, B. H. Chong, R. L. Stevens, et al. Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor Blood, January 1, 2006; 107(1): 135 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. de Paulis, N. Prevete, I. Fiorentino, A. F. Walls, M. Curto, A. Petraroli, V. Castaldo, P. Ceppa, R. Fiocca, and G. Marone Basophils Infiltrate Human Gastric Mucosa at Sites of Helicobacter pylori Infection, and Exhibit Chemotaxis in Response to H. pylori-derived Peptide Hp(2-20) J. Immunol., June 15, 2004; 172(12): 7734 - 7743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bannert, K. Vollhardt, B. Asomuddinov, M. Haag, H. Konig, S. Norley, and R. Kurth PDZ Domain-mediated Interaction of Interleukin-16 Precursor Proteins with Myosin Phosphatase Targeting Subunits J. Biol. Chem., October 24, 2003; 278(43): 42190 - 42199. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
